Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;18(3):137-169.
doi: 10.36131/cnfioritieditore20210303.

Neuroenhancement: State of the Art and Future Perspectives

Donatella Marazziti  1   2 , Maria Teresa Avella  1 , Tea Ivaldi  1 , Stefania Palermo  1 , Lucia Massa  1 , Alessandra Della Vecchia  1 , Lucia Basile  1 , Federico Mucci  3
Affiliations

Neuroenhancement: State of the Art and Future Perspectives

Donatella Marazziti et al. Clin Neuropsychiatry. 2021 Jun.

Abstract

Pharmacological neuroenhancement refers to the non-medical use of prescription drugs, alcohol, illegal drugs, or the so-called soft enhancers for the purpose of improving cognition, mood, pro-social behavior, or work and academic performance. This phenomenon is undoubtedly more frequent than previously supposed especially amongst university students. The aim of the present paper was to carefully review and comment on the available literature on neuroenhancement, according to Prisma guidelines. The results showed a great use of all prescribed drugs (benzodiazepines, antidepressants, antipsychotics, nootropic compounds, and especially stimulants) as neuroenhancers amongst healthy subjects, although probably the real prevalence is underestimated. The use of illicit drugs and soft enhancers is similarly quite common. Data on the improvement of cognition by other compounds, such as oxytocin and pheromones, or non-pharmacological techniques, specifically deep brain stimulation and transcranial magnetic stimulation, are still limited. In any case, if it is true that human beings are embedded by the desire to overcome the limits of their intrinsic nature, neuroenhancement practices put into question the concept of authenticity. Therefore, the problem appears quite complex and requires to be deepened and analyzed with no prejudice, although within an ethical conceptual frame.

Keywords: drugs; neuroenhancement; university students.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None.

Similar articles

See all similar articles

References

    1. Abdel-Wahab, B. A., & Abd El-Aziz, S. M. (2012). Ginkgo biloba protects against intermittent hypoxia-induced memory deficits and hippocampal DNA damage in rats. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 19(5), 444-450. 10.1016/j.phymed.2011.11.011 - DOI - PubMed
    1. Ahmed, A. H., & Oswald, R. E. (2010). Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. Journal of Medicinal Chemistry, 53(5), 2197-2203. 10.1021/jm901905j - DOI - PMC - PubMed
    1. Alkuraishy, H. M., Algareeb, A. I., Albuhadilly, A. K., & Almgoter, B. M. (2014). Modulation effects of piracetam and Ginkgo biloba on the cognitive and working memory functions: Psychometric study. Journal of Neurology & Neurophysiology, 5(5), 234. 10.4172/2155-9562.1000234 - DOI
    1. Andari, E., Duhamel, J. R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010). Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proceedings of the National Academy of Sciences of the United States of America, 107(9), 4389-4394. 10.1073/pnas.0910249107 - DOI - PMC - PubMed
    1. Anderson, T., Petranker, R., Rosenbaum, D., Weissman, C. R., Dinh-Williams, L. A., Hui, K., Hapke, E., & Farb, N. (2019). Microdosing psychedelics: Personality, mental health, and creativity differences in microdosers. Psychopharmacology, 236(2), 731-740. 10.1007/s00213-018-5106-2 - DOI - PubMed

LinkOut - more resources